arrow
A

Atte Meretoja

university of helsinki
H指数:90
被引数:19.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Global, regional, and national burden of headache disorders, 1990–2021, with forecasts to 2050: A Global Burden of Disease study 2021

全球、区域和国家头痛障碍负担,1990—2021年,并预测至2050年:一项2021年全球疾病负担研究

2025-09-180
OAAI
A systematic review of current national hospital-based stroke registries monitoring access to evidence-based care and patient outcomes

对当前基于国家医院的中风登记处的系统评价,以监测对循证护理的访问和患者结果

2025-01-210
PRE
Tranexamic Acid Within 4.5 Hours of Intracerebral Hemorrhage With the CTA Spot Sign Systematic Review and Individual Patient Meta-analysis
2024-12-240
PRE
Pre-COVID life expectancy, mortality, and burden of diseases for adults 70 years and older in Australia: a systematic analysis for the Global Burden of Disease 2019 Study

澳大利亚70岁及以上成年人的预期寿命、死亡率和疾病负担: 全球疾病负担2019研究的系统分析

2024-06-010
OAAI
The state of health in the European Union (EU-27) in 2019: a systematic analysis for the Global Burden of Disease study 2019

欧盟 (EU-27) 2019年的健康状况: 全球疾病负担研究的系统分析2019

2024-05-2210
OAAI
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021

1990至2021 204个国家和地区以及811个地方的371疾病和伤害的全球发病率,患病率,残疾寿命 (YLDs),残疾调整寿命 (DALYs) 和健康预期寿命 (HALE): 全球疾病负担研究2021的系统分析

LANCET
IF88.5
2024-05-01285
OAAI
Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

1950至2021 204个国家和地区的全球生育率,预测到2100: 全球疾病负担研究2021的综合人口分析

LANCET
IF88.5
2024-05-0143
OAAI
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021

2022至2050 204个国家和地区的疾病负担情景: 全球疾病负担研究2021的预测分析

LANCET
IF88.5
2024-05-0179
OAAI
Management of Poststroke Hyperglycemia: Results of the TEXAIS Randomized Clinical Trial

卒中后高血糖的管理: TEXAIS随机临床试验的结果

STROKE
IF8.9
2023-12-019
OAAI
Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026

对大流行病防范和新型冠状病毒肺炎的全球投资: 发展援助和卫生1990年和2026的国内支出

2023-03-01140
OAAI
Tenecteplase versus alteplase for stroke thrombolysis evaluation (TASTE): A multicentre, prospective, randomized, open-label, blinded-endpoint, controlled phase III non-inferiority trial protocol

替奈普酶与阿替普酶用于卒中溶栓评价 (TASTE): 一项多中心、前瞻性、随机、开放标签、盲法终点、对照III期非劣效性试验方案

2023-02-024
OA
Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019

1990至2019,对204个国家和地区的整体和选定年龄组的医疗保健获取和质量指数的评估: 来自全球疾病负担研究2019的系统分析

2022-12-0168
OAAI
Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019

青少年运输和意外伤害: 使用全球疾病负担研究2019的系统分析

2022-08-0138
OA
The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study

中欧、东欧和西欧次区域的伤害负担: 来自全球疾病负担2019研究的系统分析

2022-05-2030
OAAI
Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study

70岁及以上成年人的全球、区域和国家疾病和伤害负担: 全球疾病负担2019研究的系统分析

2022-03-10126
OAAI
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

全球痴呆症2019年患病率的估计和预测患病率2050年: 全球疾病负担研究2019的分析

2022-02-01873
OA
Does tranexamic acid affect intraventricular hemorrhage growth in acute ICH? An analysis of the STOP-AUST trial

氨甲环酸是否影响急性ICH中脑室内出血的增长?STOP-AUST审判分析

2022-02-015
OA